Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relay Therapeutics

3.36
+0.12003.70%
Post-market: 3.20-0.1597-4.75%19:41 EDT
Volume:1.77M
Turnover:5.95M
Market Cap:576.06M
PE:-1.54
High:3.45
Open:3.30
Low:3.28
Close:3.24
Loading ...

Relay Therapeutics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
28 Feb

Stock Track | Relay Therapeutics Plummets 13.33% as Missed Revenue Expectations and Losses Weigh on Shares

Stock Track
·
27 Feb

Relay Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

TD Cowen Sticks to Their Buy Rating for Relay Therapeutics (RLAY)

TIPRANKS
·
27 Feb

Relay Therapeutics reports Q4 EPS (45c), consensus (55c)

TIPRANKS
·
27 Feb

Relay Therapeutics Q4 GAAP EPS $(0.45) Beats $(0.58) Estimate

Benzinga
·
27 Feb

BRIEF-Relay Therapeutics Q4 Net Income USD -76.004 Million

Reuters
·
27 Feb

Relay Therapeutics Q4 Basic EPS USD -0.45

THOMSON REUTERS
·
27 Feb

Relay Therapeutics Q4 Operating Expenses USD 84.979 Million

THOMSON REUTERS
·
27 Feb

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

GlobeNewswire
·
27 Feb

Relay Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview

Reuters
·
25 Feb

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Positive Outlook for Relay Therapeutics: Buy Rating on Promising RLY-2680 Developments and Market Opportunities

TIPRANKS
·
29 Jan

Relay Therapeutics Inc (RLAY): AI-Driven Cancer Treatments Backed by Barclays’ $17 Price Target

Insider Monkey
·
25 Jan

We're Keeping An Eye On Relay Therapeutics' (NASDAQ:RLAY) Cash Burn Rate

Simply Wall St.
·
17 Jan

Relay Therapeutics (RLAY) Gets a Buy from Barclays

TIPRANKS
·
17 Jan

Relay Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Relay Therapeutics: Positioned for Success with Best-in-Class PI3Kα Inhibitor RLY-2608

TIPRANKS
·
14 Jan

Is Relay Therapeutics (RLAY) the Best Biotech Penny Stock to Invest in Now?

Insider Monkey
·
31 Dec 2024

Relay Therapeutics (RLAY) Moves to Buy: Rationale Behind the Upgrade

Zacks
·
21 Dec 2024